Effects of the putative transcriptional regulator Ic1R on Francisella tularensis pathogenesis

Infection and Immunity

Volumn 78, Issue 12, 2010, Pages 5022-5032

  Mortensen, Brittany L ^a   Fuller, James R ^a   Taft Benz, Sharon ^a   Kijek, Todd M ^a   Miller, Cheryl N ^a   Huang, Max T H ^a   Kawula, Thomas H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; LIVE VACCINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ICLR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; FRANCISELLA; FRANCISELLA HOLARCTICA; FRANCISELLA TULARENSIS; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE LOCUS; INOCULATION; MACROPHAGE; MICROARRAY ANALYSIS; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TULAREMIA; WILD TYPE;

ANIMALS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRANCISELLA TULARENSIS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TULAREMIA;

EID: 78649943711     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00544-10     Document Type: Article

References (53)

1. Anthony, L. D., R. D. Burke, and F. E. Nano. 1991. Growth of Francisella spp. in rodent macrophages. Infect. Immun. 59:3291-3296.
2. Birdsell, D. N., T. Stewart, A. J. Vogler, E. Lawaczeck, A. Diggs, T. L. Sylvester, J. L. Buchhagen, R. K. Auerbach, P. Keim, and D. M. Wagner. 2009. Francisella tularensis subsp. novicida isolated from a human in Arizona. BMC Res. Notes 2:223.
3. Bosio, C. M., and S. W. Dow. 2005. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175:6792-6801.
4. Centers for Disease Control and Prevention. 2005. Tularemia transmitted by insect bites - Wyoming, 2001-2003. MMWR Morb. Mortal. Wkly. Rep. 54: 170-173.
5. Centers for Disease Control and Prevention. 2009. Tularemia - Missouri, 2000-2007. MMWR Morb. Mortal. Wkly. Rep. 58:744-748.
6. Chamberlain, R. E. 1965. Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol. 13:232-235.
7. Champion, M. D., Q. Zeng, E. B. Nix, F. E. Nano, P. Keim, C. D. Kodira, M. Borowsky, S. Young, M. Koehrsen, R. Engels, M. Pearson, C. Howarth, L. Larson, J. White, L. Alvarado, M. Forsman, S. W. Bearden, A. Sjostedt, R. Titball, S. L. Michell, B. Birren, and J. Galagan. 2009. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog. 5:e1000459.
8. Child, R., T. D. Wehrly, D. Rockx-Brouwer, D. W. Dorward, and J. Celli. 2010. Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis. Infect. Immun. 78:59-67.
9. Clarridge, J. E., III, T. J. Raich, A. Sjosted, G. Sandstrom, R. O. Darouiche, R. M. Shawar, P. R. Georghiou, C. Osting, and L. Vo. 1996. Characterization of two unusual clinically significant Francisella strains. J. Clin. Microbiol. 34:1995-2000.
10. Clemens, D. L., B. Y. Lee, and M. A. Horwitz. 2004. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun. 72:3204-3217.
11. Cole, L. E., K. L. Elkins, S. M. Michalek, N. Qureshi, L. J. Eaton, P. Rallabhandi, N. Cuesta, and S. N. Vogel. 2006. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J. Immunol. 176:6888-6899.
12. Cole, L. E., A. Santiago, E. Barry, T. J. Kang, K. A. Shirey, Z. J. Roberts, K. L. Elkins, A. S. Cross, and S. N. Vogel. 2008. Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways. J. Immunol. 180:6885-6891.
13. Cowley, S. C., C. J. Gray, and F. E. Nano. 2000. Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis. FEMS Microbiol. Lett. 182:63-67.
14. Deng, K., R. J. Blick, W. Liu, and E. J. Hansen. 2006. Identification of Francisella tularensis genes affected by iron limitation. Infect. Immun. 74: 4224-4236.
15. Dennis, D. T., T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, M. Layton, S. R. Lillibridge, J. E. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, K. Tonat, and the Working Group on Civilian Biodefense. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285:2763-2773.
16. Duque, E., A. Segura, G. Mosqueda, and J. L. Ramos. 2001. Global and cognate regulators control the expression of the organic solvent efflux pumps TtgABC and TtgDEF of Pseudomonas putida. Mol. Microbiol. 39:1100-1106.
17. Elkins, K. L., R. K. Winegar, C. A. Nacy, and A. H. Fortier. 1992. Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb. Pathog. 13:417-421.
18. Feldman, K. A., R. E. Enscore, S. L. Lathrop, B. T. Matyas, M. McGuill, M. E. Schriefer, D. Stiles-Enos, D. T. Dennis, L. R. Petersen, and E. B. Hayes. 2001. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N. Engl. J. Med. 345:1601-1606.
19. Fortier, A. H., M. V. Slayter, R. Ziemba, M. S. Meltzer, and C. A. Nacy. 1991. Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59:2922-2928.
20. Fuller, J. R., R. R. Craven, J. D. Hall, T. M. Kijek, S. Taft-Benz, and T. H. Kawula. 2008. RipA, a cytoplasmic membrane protein conserved among Francisella species, is required for intracellular survival. Infect. Immun. 76:4934-4943.
21. Gallagher, L. A., E. Ramage, M. A. Jacobs, R. Kaul, M. Brittnacher, and C. Manoil. 2007. A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc. Natl. Acad. Sci. U. S. A. 104:1009-1014.
22. Guazzaroni, M. E., W. Teran, X. Zhang, M. T. Gallegos, and J. L. Ramos. 2004. TtgV bound to a complex operator site represses transcription of the promoter for the multidrug and solvent extrusion TtgGHI pump. J. Bacteriol. 186:2921-2927.
23. Hall, J. D., R. R. Craven, J. R. Fuller, R. J. Pickles, and T. H. Kawula. 2007. Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation. Infect. Immun. 75:1034-1039.
24. Hollis, D. G., R. E. Weaver, A. G. Steigerwalt, J. D. Wenger, C. W. Moss, and D. J. Brenner. 1989. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J. Clin. Microbiol. 27:1601-1608.
25. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
26. Huang, M. T., B. M. Mortensen, D. J. Taxman, R. R. Craven, S. Taft-Benz, T. M. Kijek, J. R. Fuller, B. K. Davis, I. C. Allen, W. Brickey, D. Gris, H. Wen, T. H. Kawula, and J. P. Ting. 4 October 2010. Deletion of ripA alleviates suppression of the inflammasome and MAP kinase by Francisella tularensis. J. Immunol. doi:10.4049/jimmunol.1002154.
27. Kadzhaev, K., C. Zingmark, I. Golovliov, M. Bolanowski, H. Shen, W. Conlan, and A. Sjostedt. 2009. Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS One. 4:e5463.
28. Kandemir, B., I. Erayman, M. Bitirgen, E. T. Aribas, and S. Guler. 2007. Tularemia presenting with tonsillopharyngitis and cervical lymphadenitis: report of two cases. Scand. J. Infect. Dis. 39:620-622.
29. Keim, P., A. Johansson, and D. M. Wagner. 2007. Molecular epidemiology, evolution, and ecology of Francisella. Ann. N. Y. Acad. Sci. 1105:30-66.
30. Kraemer, P. S., A. Mitchell, M. R. Pelletier, L. A. Gallagher, M. Wasnick, L. Rohmer, M. J. Brittnacher, C. Manoil, S. J. Skerett, and N. R. Salama. 2009. Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice. Infect. Immun. 77:232-244.
31. Krell, T., A. J. Molina-Henares, and J. L. Ramos. 2006. The IclR family of transcriptional activators and repressors can be defined by a single profile. Protein Sci. 15:1207-1213.
32. Leelaporn, A., S. Yongyod, S. Limsrivanichakorn, T. Yungyuen, and P. Kiratisin. 2008. Francisella novicida bacteremia, Thailand. Emerg. Infect. Dis. 14:1935-1937.
33. LoVullo, E. D., L. A. Sherrill, L. L. Perez, and M. S. Pavelka, Jr. 2006. Genetic tools for highly pathogenic Francisella tularensis subsp. tularensis. Microbiology 152:3425-3435.
34. Lubbert, C., C. Taege, T. Seufferlein, and R. Grunow. 2009. Prolonged course of tick-borne ulceroglandular tularemia in a 20-year-old patient in Germany: case report and review of the literature. Dtsch. Med. Wochenschr. 134:1405-1410.
35. Maier, T. M., M. S. Casey, R. H. Becker, C. W. Dorsey, E. M. Glass, N. Maltsev, T. C. Zahrt, and D. W. Frank. 2007. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect. Immun. 75:5376-5389.
36. Mariathasan, S., D. S. Weiss, V. M. Dixit, and D. M. Monack. 2005. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202:1043-1049.
37. McCaffrey, R. L., and L. A. Allen. 2006. Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J. Leukoc. Biol. 80:1224-1230.
38. Mohapatra, N. P., S. Soni, T. J. Reilly, J. Liu, K. E. Klose, and J. S. Gunn. 2008. Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape. Infect. Immun. 76: 3690-3699.
39. Molina-Henares, A. J., T. Krell, M. Eugenia Guazzaroni, A. Segura, and J. L. Ramos. 2006. Members of the IclR family of bacterial transcriptional regulators function as activators and/or repressors. FEMS Microbiol. Rev. 30:157-186.
40. Ojeda, S. S., Z. J. Wang, C. A. Mares, T. A. Chang, Q. Li, E. G. Morris, P. A. Jerabek, and J. M. Teale. 2008. Rapid dissemination of Francisella tularensis and the effect of route of infection. BMC Microbiol. 8:215.
41. Qin, A., and B. J. Mann. 2006. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol. 6:69.
42. Ramos, J. L., E. Duque, M. T. Gallegos, P. Godoy, M. I. Ramos-Gonzalez, A. Rojas, W. Teran, and A. Segura. 2002. Mechanisms of solvent tolerance in gram-negative bacteria. Annu. Rev. Microbiol. 56:743-768.
43. Reintjes, R., I. Dedushaj, A. Gjini, T. R. Jorgensen, B. Cotter, A. Lieftucht, F. D'Ancona, D. T. Dennis, M. A. Kosoy, G. Mulliqi-Osmani, R. Grunow, A. Kalaveshi, L. Gashi, and I. Humolli. 2002. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg. Infect. Dis. 8:69-73.
44. Rohmer, L., C. Fong, S. Abmayr, M. Wasnick, T. J. Larson Freeman, M. Radey, T. Guina, K. Svensson, H. S. Hayden, M. Jacobs, L. A. Gallagher, C. Manoil, R. K. Ernst, B. Drees, D. Buckley, E. Haugen, D. Bovee, Y. Zhou, J. Chang, R. Levy, R. Lim, W. Gillett, D. Guenthener, A. Kang, S. A. Shaffer, G. Taylor, J. Chen, B. Gallis, D. A. D'Argenio, M. Forsman, M. V. Olson, D. R. Goodlett, R. Kaul, S. I. Miller, and M. J. Brittnacher. 2007. Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol. 8:R102.
45. Saeed, A. I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, A. Sturn, M. Snuffin, A. Rezantsev, D. Popov, A. Ryltsov, E. Kostukovich, I. Borisovsky, Z. Liu, A. Vinsavich, V. Trush, and J. Quackenbush. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378.
46. Saslaw, S., H. T. Eigelsbach, J. A. Prior, H. E. Wilson, and S. Carhart. 1961. Tularemia vaccine study. II. Respiratory challenge. Arch. Intern. Med. 107: 702-714.
47. Schulert, G. S., R. L. McCaffrey, B. W. Buchan, S. R. Lindemann, C. Hollenback, B. D. Jones, and L. A. Allen. 2009. Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS. Infect. Immun. 77:1324-1336.
48. Siret, V., D. Barataud, M. Prat, V. Vaillant, S. Ansart, A. Le Coustumier, J. Vaissaire, F. Raffi, M. Garre, and I. Capek. 2006. An outbreak of airborne tularaemia in France, August 2004. Euro Surveill. 11:58-60.
49. Su, J., J. Yang, D. Zhao, T. H. Kawula, J. A. Banas, and J. R. Zhang. 2007. Genome-wide identification of Francisella tularensis virulence determinants. Infect. Immun. 75:3089-3101.
50. Telepnev, M., I. Golovliov, T. Grundstrom, A. Tarnvik, and A. Sjostedt. 2003. Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell. Microbiol. 5:41-51.
51. Titball, R. W., and J. F. Petrosino. 2007. Francisella tularensis genomics and proteomics. Ann. N. Y. Acad. Sci. 1105:98-121.
52. Ulland, T. K., B. W. Buchan, M. R. Ketterer, T. Fernandes-Alnemri, D. K. Meyerholz, M. A. Apicella, E. S. Alnemri, B. D. Jones, W. M. Nauseef, and F. S. Sutterwala. 2010. Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence. J. Immunol. 185:2670-2674.
53. Weiss, D. S., A. Brotcke, T. Henry, J. J. Margolis, K. Chan, and D. M. Monack. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U. S. A. 104:6037-6042.